Skip to main content
Oncotarget logoLink to Oncotarget
. 2022 May 25;13:755. doi: 10.18632/oncotarget.28237

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells

Ilaria Guerriero 1, Daniela D’Angelo 2, Pierlorenzo Pallante 2, Mafalda Santos 1, Marianna Scrima 1, Donatella Malanga 3, Carmela De Marco 3, Maria Ravo 4, Alessandro Weisz 4, Carmelo Laudanna 3, Michele Ceccarelli 1,5, Geppino Falco 1,6, Antonia Rizzuto 7, Giuseppe Viglietto 1,3,
PMCID: PMC9132257  PMID: 35634243

This article has been corrected: In Figure 6B, the H460-SCR-EV image (upper left panel) contains accidental overlaps from the H460-shAKT1-miR-196a image (lower right panel). The corrected Figure 6B, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Figure 6. MiR-196a regulates migration and tumorigenicity of NSCLC cells.

Figure 6

(B) Boyden chamber migration assay of control NCI-H460-SCR-EV, NCI-H460-shAKT1-EV, NCI-H460-SCR-antimiR-196a and NCI-H460-shAKT1-miR-196a cells. The graph represents the mean number (±SD) of migrated cells/field. Representative images of migrated NCI-H460 and derivative cells. Magnification 10×; p < 0.001.

Original article: Oncotarget. 2017; 8:19172–19191. 19172-19191. https://doi.org/10.18632/oncotarget.13432


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES